News

WahInnovations has merged into MoreYeahs IT Technologies, enhancing our Salesforce solutions with AI and Data Engineering.

WahInnovations joined MoreYeahs.

Get in touch

AI-Driven Clinical Site Assessment Solution Accelerating 40% Faster Trial Launches and Reducing 30% Site Selection Cycle Time

AI solution for faster, compliant clinical site assessment

Feb 5, 2026
Published
MoreYeahs
Author
Artificial Intelligence, Healthcare
Tags
Overview
  • Industry: Healthcare & Life Sciences
  • Category: Artificial Intelligence
  • Engagement: AI-Driven Site Feasibility & Qualification Platform
  • Users: Sponsors, CROs & Clinical Research Associates (CRAs)
Objectives
  • Client - Clinical Research & Life Sciences domain
  • Automate protocol‑aligned site feasibility scoring
  • Generate AI‑assisted site shortlisting
  • Enforce structured CRA‑led site qualification
01 / 08

Results Snapshot

40%
Faster clinical trial launches
30%
Reduction in site selection cycle time
02 / 08

Customer

The client operates in the Clinical Research and Life Sciences space, supporting sponsor- and CRO-oriented clinical trial operations.

Trial timelines were routinely delayed by poor site selection, missing documents, staffing gaps, and regulatory issues, resulting in delayed FPFV, higher costs, protocol deviations, and heavy manual coordination overhead.

Site evaluation relied on traditional, manual workflows (manual reviews, email questionnaires, and subjective scoring) rather than a standardized, data-driven process.

03 / 08

Business Challenge

As trial volumes grew, the client's clinical operations team faced a set of operational and compliance challenges that made site selection slow, inconsistent, and difficult to audit:

01

Inconsistent Site Scoring: site evaluations relied on subjective, manual reviews rather than standardized, protocol-aligned criteria.

02

Limited Historical Insight: feasibility decisions lacked access to historical site performance data, making comparisons across sites unreliable.

03

Manual Document Verification: verifying site documentation by hand slowed reviews and left the process with poor audit readiness.

04

Fragmented CRA Qualification: CRA-led site qualification processes were fragmented, lacking digital standardization or integration into activation pipelines.

05

Undetected Early Risks: inefficient feasibility evaluations produced slow, inconsistent decisions and let operational and compliance risks go undetected until later stages.

06

Delayed Trial Startups: poor site selection, missing documents, staffing gaps, and regulatory issues delayed FPFV, increased costs, and caused protocol deviations.

04 / 08

Solution

The solution leverages AI agents to automate sequential clinical site evaluation, with validated handoffs between feasibility and pre-activation stages so that only qualified sites advance to contracting and activation.

Feasibility Agent: assesses site suitability against protocol requirements and historical performance data to generate AI-assisted site shortlisting.

Pre-Activation Agent: verifies operational readiness, confirming documents, staffing, and compliance checks are complete before a site can proceed.

Sequential AI Workflows: validated handoffs between feasibility and pre-activation stages eliminate subjective site selection and detect risks early.

Structured CRA Qualification: enforces structured, CRA-led site qualification, digitizing what was previously a manual, fragmented process.

Compliance & Audit Trails: generates inspection-ready audit trails and secure compliance workflows throughout the evaluation process.

Configurable AI Scoring: protocol-driven automation and configurable AI scoring, with mandatory CRA validation built into every decision.

05 / 08

Implementation

The clinical site evaluation process was implemented as a sequential, agent-driven workflow that moves each site from initial protocol input to an activation-ready decision.

Protocol Input: trial protocol requirements are fed into the platform as the starting point for site evaluation.

Feasibility Assessment: the Feasibility Agent performs scraping, scoring, questionnaire processing, and validation to shortlist suitable sites based on protocol requirements and historical data.

Pre-Activation Verification: shortlisted sites move to the Pre-Activation Agent, which handles CRA onboarding, SQV (Site Qualification Visit) checklists, document validation, and scheduling.

AI-Driven Qualification: the Pre-Activation Agent applies AI-driven qualification checks, confirming staffing, documentation, and compliance are complete.

Activation Readiness: only sites that pass both stages are marked activation-ready, with a structured, inspection-ready audit trail generated at each step.

06 / 08

Technology

Backend Framework: FastAPI, Python 3.10+.Workflow Orchestration: LangGraph for event-driven, agent-based workflow management.Data Storage: PostgreSQL.Automation & Scraping: Selenium for site data scraping.Security & Access: JWT-based Role-Based Access Control (RBAC).Deployment: Docker containers for scalability and maintainability.
07 / 08

Results

The AI-driven site evaluation platform delivered measurable improvements in trial startup speed and site selection efficiency.

40%
faster clinical trial launches
30%
reduction in site selection cycle time
08 / 08

Business Impact

Beyond faster site evaluation, the platform gives the client a more consistent, audit-ready, and scalable approach to clinical trial startups.

01

Higher Selection Accuracy: AI-driven automation improves accuracy and consistency in site evaluation, reducing the risk of subjective or error-prone decisions.

02

Fewer Manual Errors: structured workflows and sequential agent handoffs reduce manual errors and keep the client audit- and compliance-ready.

03

Earlier Risk Detection: early detection of operational and regulatory risks helps the client avoid delays and costly site failures before they happen.

04

Balanced Automation & Oversight: integrating mandatory CRA validation with AI insights lets the client scale automation without losing human oversight.

05

Stronger Audit Readiness: end-to-end, inspection-ready audit trails strengthen regulatory preparedness and traceability across every site decision.

06

Fewer Activation Failures: reduced site activation failures and improved operational efficiency support more reliable trial startups going forward.

Let's scope your next platform.

Tell us where you're headed. You'll get a senior architect on the first call, a working consultation, not a sales pitch.

Response within one business day from a technical lead, not a bot.
NDA on request before you share anything sensitive.
Prefer to book directly? Grab a 30-min architecture slot on our calendar.